Literature DB >> 33879853

The UK practice of Anti-VEGF therapy for treatment of retinopathy of prematurity.

Shahanaz B Ahmed1, Aisling Higham2, Alan Mulvihill3,4, T K J Chan3,4, Gill Adams5,6, Chetan K Patel2,6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33879853      PMCID： PMC8377112          DOI： 10.1038/s41433-021-01543-9

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   4.456


× No keyword cloud information.
  3 in total

1.  Reducing oral flora contamination of intravitreal injections with face mask or silence.

Authors:  Rishi R Doshi; Theodore Leng; Anne E Fung
Journal:  Retina       Date:  2012-03       Impact factor: 4.256

Review 2.  Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.

Authors:  Mari Jeeva Sankar; Jhuma Sankar; Parijat Chandra
Journal:  Cochrane Database Syst Rev       Date:  2018-01-08

3.  Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection.

Authors:  Elcin Suren; Ersan Cetinkaya; Mustafa Kalayci; Sariye Elif Özyazıcı Özkan; Mehmet Fatih Kucuk; Muhammet Kazim Erol
Journal:  Case Rep Ophthalmol Med       Date:  2020-12-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.